» Articles » PMID: 11461749

Clinical Determinants of Increased QT Dispersion in Patients with Diabetes Mellitus

Overview
Journal Int J Cardiol
Publisher Elsevier
Date 2001 Jul 20
PMID 11461749
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To compare QT dispersion measurements in diabetic patients to control subjects and assess any associations between QT dispersion and diabetic clinical characteristics.

Methods: A total of 512 diabetics and 50 age and gender matched controls were studied. QT interval was measured manually in 12-lead conventional electrocardiograms, and QT dispersion (QTd), heart rate-corrected QT dispersion (QTcd), number of leads-adjusted QT dispersion (adjuQTd) and adjacent QT dispersion (adjaQTd) were calculated. Demographic, clinical, laboratory and electrocardiographic data were recorded.

Results: Diabetics showed increased QT dispersion compared to controls (QTd: P<0.001, QTcd: P<0.001, adjuQTd: P<0.001), even those with recent diagnosis (less than 2 years) and without arterial hypertension, ECG abnormalities or chronic degenerative complications (QTd: P=0.01, QTcd: P<0.001, adjuQTd: P=0.04). Left ventricular hypertrophy (QTd: P<0.001, QTcd: P<0.001, adjuQTd: P<0.001, adjaQTd: P<0.001) and conduction disturbances (QTd: P=0.002, QTcd: P=0.003, adjuQTd: P=0.003) were the electrocardiographic findings associated with increased QT dispersion in bivariate analysis. Clinical variables were the presence of arterial hypertension (QTd: P=0.004, QTcd: P=0.01, adjuQTd: P<0.001), even without left ventricular hypertrophy (QTd: P=0.01, QTcd: P=0.03, adjuQTd: P=0.003), and the presence of diabetic cardiovascular complications (QTd: P=0.02, QTcd: P=0.01, adjuQTd: P=0.008, adjaQTd: P=0.03). No association between QT dispersion and the presence of diabetic microvascular complications, glycaemic control, age and gender, or cardiovascular drugs was observed. Multivariate regressive statistical analysis confirmed the associations noted in bivariate analysis.

Conclusions: Diabetic patients have increased QT dispersion compared to non-diabetics even those without arterial hypertension and cardiovascular complications and with recent diagnosis. The presence of arterial hypertension, diabetic cardiovascular complications and electrocardiographic abnormalities of left ventricular hypertrophy and conduction disturbances were associated to increased QT dispersion in diabetes mellitus.

Citing Articles

Exploring electrocardiographic alterations and the prolongation of QT interval in patients with diabetes mellitus.

Arya T, Kumar R, Aziz T, Alam M, Kujur A J Family Med Prim Care. 2024; 13(11):5033-5039.

PMID: 39723001 PMC: 11668398. DOI: 10.4103/jfmpc.jfmpc_747_24.


Toluene Inhalant Addiction and Cardiac Functions in Young Adults: A Comparison of Electrocardiographic and Echocardiographic Parameters.

Karaca G, Hatipsoylu E, Ekmekci A, Yazici O, Kimiaei A, Safaei S Clin Cardiol. 2024; 47(11):e70037.

PMID: 39445684 PMC: 11500041. DOI: 10.1002/clc.70037.


Electrical Features of the Diabetic Myocardium. Arrhythmic and Cardiovascular Safety Considerations in Diabetes.

Gallego M, Zayas-Arrabal J, Alquiza A, Apellaniz B, Casis O Front Pharmacol. 2021; 12:687256.

PMID: 34305599 PMC: 8295895. DOI: 10.3389/fphar.2021.687256.


Handling of Ventricular Fibrillation in the Emergency Setting.

Szabo Z, Ujvarosy D, Otvos T, Sebestyen V, Nanasi P Front Pharmacol. 2020; 10:1640.

PMID: 32140103 PMC: 7043313. DOI: 10.3389/fphar.2019.01640.


Evaluation of cardiac hypertrophy in the setting of sudden cardiac death.

Cunningham K, Spears D, Care M Forensic Sci Res. 2019; 4(3):223-240.

PMID: 31489388 PMC: 6713129. DOI: 10.1080/20961790.2019.1633761.